Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | JAK1 |
Variant | Y654F |
Impact List | missense |
Protein Effect | gain of function - predicted |
Gene Variant Descriptions | JAK1 Y654F lies within protein kinase domain 1 of the Jak1 protein (UniProt.org). Y654F demonstrated constitutive activation of JAK-STAT signaling in primary cells in culture (PMID: 26415585), and therefore, is predicted to lead to a gain of Jak1 protein function. |
Associated Drug Resistance | |
Category Variants Paths |
JAK1 mutant JAK1 act mut JAK1 Y654F |
Transcript | NM_002227.4 |
gDNA | chr1:g.64846675T>A |
cDNA | c.1961A>T |
Protein | p.Y654F |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001321854.1 | chr1:g.64846675T>A | c.1961A>T | p.Y654F | RefSeq | GRCh38/hg38 |
NM_001321852.1 | chr1:g.64846675T>A | c.1961A>T | p.Y654F | RefSeq | GRCh38/hg38 |
NM_001321853.2 | chr1:g.64846675T>A | c.1961A>T | p.Y654F | RefSeq | GRCh38/hg38 |
XM_047419675.1 | chr1:g.64846675T>A | c.1961A>T | p.Y654F | RefSeq | GRCh38/hg38 |
NM_001320923.1 | chr1:g.64846675T>A | c.1961A>T | p.Y654F | RefSeq | GRCh38/hg38 |
NM_001321856 | chr1:g.64846675T>A | c.1961A>T | p.Y654F | RefSeq | GRCh38/hg38 |
NM_002227 | chr1:g.64846675T>A | c.1961A>T | p.Y654F | RefSeq | GRCh38/hg38 |
NM_001320923.2 | chr1:g.64846675T>A | c.1961A>T | p.Y654F | RefSeq | GRCh38/hg38 |
NM_002227.4 | chr1:g.64846675T>A | c.1961A>T | p.Y654F | RefSeq | GRCh38/hg38 |
NM_001321852 | chr1:g.64846675T>A | c.1961A>T | p.Y654F | RefSeq | GRCh38/hg38 |
NM_001321855 | chr1:g.64846675T>A | c.1961A>T | p.Y654F | RefSeq | GRCh38/hg38 |
NM_001321854.2 | chr1:g.64846675T>A | c.1961A>T | p.Y654F | RefSeq | GRCh38/hg38 |
NM_001321852.2 | chr1:g.64846675T>A | c.1961A>T | p.Y654F | RefSeq | GRCh38/hg38 |
NM_001321856.2 | chr1:g.64846675T>A | c.1961A>T | p.Y654F | RefSeq | GRCh38/hg38 |
XM_047419674.1 | chr1:g.64846675T>A | c.1961A>T | p.Y654F | RefSeq | GRCh38/hg38 |
NM_002227.3 | chr1:g.64846675T>A | c.1961A>T | p.Y654F | RefSeq | GRCh38/hg38 |
NM_001321855.1 | chr1:g.64846675T>A | c.1961A>T | p.Y654F | RefSeq | GRCh38/hg38 |
NM_001320923 | chr1:g.64846675T>A | c.1961A>T | p.Y654F | RefSeq | GRCh38/hg38 |
NM_001321853 | chr1:g.64846675T>A | c.1961A>T | p.Y654F | RefSeq | GRCh38/hg38 |
NM_001321856.1 | chr1:g.64846675T>A | c.1961A>T | p.Y654F | RefSeq | GRCh38/hg38 |
NM_001321855.2 | chr1:g.64846675T>A | c.1961A>T | p.Y654F | RefSeq | GRCh38/hg38 |
NM_001321854 | chr1:g.64846675T>A | c.1961A>T | p.Y654F | RefSeq | GRCh38/hg38 |
NM_001321853.1 | chr1:g.64846675T>A | c.1961A>T | p.Y654F | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
JAK1 Y654F | Sezary's disease | sensitive | Pyridone 6 | Preclinical - Cell culture | Actionable | In a preclinical study, Pyridone 6 (CMP6) inhibited proliferation of cells derived from a Sezary syndrome patient harboring JAK1 Y654F in culture (PMID: 26415585). | 26415585 |
JAK1 Y654F | Sezary's disease | sensitive | Ruxolitinib | Preclinical - Patient cell culture | Actionable | In a preclinical study, Jakafi (ruxolitinib) inhibited growth of primary cells derived from a Sezary syndrome patient harboring JAK1 Y654F in culture (PMID: 26415585). | 26415585 |